We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Dexmedetomidine Nitroso Impurity
Dexmedetomidine Nitroso Impurity
CAT No SRC-N0141970
CAS No NA
Mol.F. C13H15N3O
Mol.Wt. 229.3 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Albendazole Impurity 1
N-Nitroso Albendazole Impurity 1
CAT No SRC-N0141971
CAS No NA
Mol.F. C12H13N3O3S
Mol.Wt. 279.31g/mol
INV STATUS IN STOCK
N-Nitrosoantipyrine
N-Nitrosoantipyrine
CAT No SRC-N0141972
CAS No 885-11-0
Mol.F. C11H11N3O2
Mol.Wt. 217.23 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Apramycin
N-Nitroso Apramycin
CAT No SRC-N0141973
CAS No NA
Mol.F. C21H40N6O12
Mol.Wt. 568.58 g/mol
INV STATUS CUSTOM SYNTHESIS
Acalabrutinib Nitroso Impurity 1
Acalabrutinib Nitroso Impurity 1
CAT No SRC-N0141974
CAS No NA
Mol.F. C22H20N8O2
Mol.Wt. 428.46 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Alosetron
N-Nitroso Alosetron
CAT No SRC-N0141975
CAS No NA
Mol.F. C17H17N5O2
Mol.Wt. 323.36 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Amikacin
N-Nitroso Amikacin
CAT No SRC-N0141976
CAS No NA
Mol.F. C22H42N6O14
Mol.Wt. 614.61 g/mol
INV STATUS CUSTOM SYNTHESIS
N- Nitroso Ramipril Impurity C
N- Nitroso Ramipril Impurity C
CAT No SRC-N0141977
CAS No NA
Mol.F. C23H37N3O6
Mol.Wt. 451.56 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Scopolamine EP Impurity A
N-Nitroso Scopolamine EP Impurity A
CAT No SRC-N0141978
CAS No NA
Mol.F. C16H18N2O5
Mol.Wt. 318.33 g/mol
INV STATUS CUSTOM SYNTHESIS
Mifepristone Ethylene-Ani-Pynyelone Nitroso Impurity | N-Nitroso Mifepristone Impurity 17
Mifepristone Ethylene-Ani-Pynyelone Nitroso Impurity | N-Nitroso Mifepristone Impurity 17
CAT No SRC-N0141979
CAS No NA
Mol.F. C30H38N2O5
Mol.Wt. 506.64 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Venlafaxine EP Impurity H
N-Nitroso Venlafaxine EP Impurity H
CAT No SRC-N0141980
CAS No NA
Mol.F. C24H32N2O4
Mol.Wt. 412.5 g/mol
INV STATUS IN STOCK
N-Nitroso Venlafaxine Impurity 3
N-Nitroso Venlafaxine Impurity 3
CAT No SRC-N0141981
CAS No NA
Mol.F. C10H14N2O2
Mol.Wt. 194.2 g/mol
INV STATUS IN STOCK
N-Nitroso Venlafaxine Impurity 4
N-Nitroso Venlafaxine Impurity 4
CAT No SRC-N0141982
CAS No NA
Mol.F. C16H22N2O3
Mol.Wt. 290.4 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Venlafaxine Impurity 5
N-Nitroso Venlafaxine Impurity 5
CAT No SRC-N0141983
CAS No NA
Mol.F. C16H22N2O2
Mol.Wt. 274.4 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Venlafaxine Impurity 6
N-Nitroso Venlafaxine Impurity 6
CAT No SRC-N0141984
CAS No NA
Mol.F. C16H24N2O2
Mol.Wt. 276.4 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Clonixin
N-Nitroso Clonixin
CAT No SRC-N0141985
CAS No NA
Mol.F. C13H10ClN3O3
Mol.Wt. 291.69 g/mol
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.